Lista de obras -

A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

scientific article published on 01 December 2008

Construction and isolation of recombinant MVA.

artículo científico publicado en 2004

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

artículo científico publicado en 2007

Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.

artículo científico publicado en 2002

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

artículo científico publicado en 2003

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

artículo científico publicado en 2003

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

artículo científico publicado en 2002

Improved host range selection for recombinant modified vaccinia virus Ankara

artículo científico publicado en 2003

In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences

artículo científico publicado en 2008

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

artículo científico publicado en 2005

Live viral vectors: vaccinia virus

artículo científico publicado en 2003

Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection

artículo científico publicado en 2008

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

artículo científico publicado en 2004

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

artículo científico publicado en 2004

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

artículo científico publicado en 2005

Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model

artículo científico publicado en 2008

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model

artículo científico publicado en 2007

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

artículo científico publicado en 2003

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

artículo científico publicado en 2005

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

artículo científico publicado en 2006

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

artículo científico publicado en 2008

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

artículo científico publicado en 2009

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

artículo científico publicado en 2008

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

artículo científico publicado en 2007

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

artículo científico publicado en 2003

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation

artículo científico publicado en 2009

Lista de obras de

A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

Construction and isolation of recombinant MVA.

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Improved host range selection for recombinant modified vaccinia virus Ankara

In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

Live viral vectors: vaccinia virus

Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation